Recently, it has been reported that curcumin, which is known as a potent antioxidant, acts as a nonstressful and non-cytotoxic inducer of the cytoprotective heme oxygenase (HO)-1. In this study, naturally occurring curcuminoids, such as pure curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC), were compared for their potential ability to modulate HO-1 expression and cytoprotective activity in human endothelial cells. All three curcuminoids could induce HO-1 expression and HO activity with differential levels. The rank order of HO activity was curcumin, DMC and BDMC. In comparison with endothelial protection against H2O2-induced cellular injury, cytoprotective capacity was found to be highest with curcumin, followed by DMC and BDMC. Interestingly, cytoprotective effects afforded by curcuminoids were considerably associated with their abilities to enhance HO activity. Considering that the main difference among the three curcuminoids is the number of methoxy groups (none for BDMC, one for DMC, and two for curcumin), the presence of methoxy groups in the ortho position on the aromatic ring was suggested to be essential to enhance HO-1 expression and cytoprotection in human endothelial cells. Our results may be useful in designing more efficacious HO-1 inducers which could be considered as promising pharmacological agents in the development of therapeutic approaches for the prevention or treatment of endothelial diseases caused by oxidative damages.
Introduction
The rhizome of Curcuma longa (turmeric) has been widely used as a spice and coloring agent in many foods. Consumption of turmeric has been associated with various beneficial effects on human health (Duvoix et al., 2005) . Turmeric has also been used as a traditional remedy for the treatment of inflammation and other diseases (Joe et al., 2004) . The major components of turmeric are the curcuminoids that include curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC) (Chainani-Wu, 2003) . Their chemical structures are illustrated in Figure 1 . Ongoing experimental and clinical studies suggest that curcumin and its curcuminoids exhibit unique cytoprotective (Scapagnini et al., 2002) , antiinflammatory (Selvam et al., 2005) and anticancer properties . In recent years, it has also been reported that curcumin acts as a non-stressful and non-cytotoxic inducer of the cytoprotective heme oxygenase (HO)-1 and can maximize the intrinsic antioxidant potential of cells (Motterlini et al., 2000) . Whether other derivatives of curcumin present in turmeric, such as DMC and BDMC, would also stimulate this enzyme induction remains to be investigated.
Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection HO is a cytoprotective enzyme, in response to oxidative injury, whose main function is inherently associated with the degradation of oxidative heme to biliverdin, free iron, and carbon monoxide (Kikuchi et al., 2005) . Subsequently, biliverdin is rapidly metabolized into bilirubin by cytosolic biliverdin reductase, and free iron is sequestered by ferritin (Kikuchi et al., 2005) . Three isoforms of HO have been identified as referred to HO-1, HO-2 and HO-3. Although HO-2 and HO-3 are constitutively expressed, HO-1 is inducible in many cell types, including human endothelial cells (Balla et al., 2005) . Numerous studies have shown that HO-1 has cytoprotective and anti-inflammatory properties (Choi et al., 2003; Pae et al., 2004; Pae et al., 2005; Pae et al., 2006) and, interestingly, its expression mediates cytoprotective and anti-inflammatory effects of naturally occurring antioxidants such as curcumin (Motterlini et al., 2000) and quercetin (Chow et al., 2005) .
When the blood vessel is injured, in many cases, by oxidative stress, a variety of pro-inflammatory mediators and growth factors are produced mainly by injured/activated endothelial cells, and stimulate vascular smooth muscle cells to migrate into the intimal layer and expand, eventually followed by endothelial dysfunction (Yu and Lyons, 2005) . Recent studies have shown that HO-1 expression protects endothelial cells from oxidative injury and reduces the production of pro-inflammatory mediators by endothelial cells (Balla et al., 2005) , suggesting that endothelial HO-1 has roles in cytoprotection as well as in the regulation of inflammation. In addition, human HO-1 deficiency results in severe persistent endothelial damage (Kawashima et al., 2002) . Thus, genetic or pharmacological induction of endothelial HO-1 would be effective for the prevention and treatment of several endothelial diseases caused by oxidative damages.
In the present study, we evaluated the comparative effects of curcumin and its two naturally occurring derivatives, DMC and BDMC, on endothelial HO-1 expression. In addition, we investigated whether the cytoprotective activities of curcuminoids could be associated with their ability to induce endothelial HO-1 expression.
Materials and Methods

Materials
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumb romide (MTT) was purchased from Sigma (St. Louis, MO), and antibodies against HO-1 and actin from Santa Cruz Biotechnology (Santa Cruz, CA). Cobalt protoporphyrin (CoPP), hemin and tin protoporphyrin (SnPP) were obtained from Porphyrin Products (Logan, UT). Other chemicals were purchased from Sigma.
Isolation and purification of curcumin and its two derivatives
Dried and pulverized rhizome of Curcuma longa (600 g), which was purchased from the University Oriental herbal drugstore in Korea, was extracted twice with ethyl alcohol (2 L) for 24 h at room temperature to obtain an extract (51.63 g). The extract was dissolved in 60% aqueous methanol (1 L) and partitioned with n-hexane (1 L × 3), followed by CHCl3 (1 L × 3). The 60% aqueous methanol layer was then evaporated in vacuum, and the resulting residue was dissolved in H2O and successively partitioned with normal butanol (1 L × 3). A portion (10 g) of the bioactive CHCl3 soluble extract was subjected to silica gel column chromatography eluting with CHCl3-CH3OH (80:1-16:1, step gradient) to yield compound 1 (2.21 g), compound 2 (0.34 g) and compound 3 (1.30 g). The compounds were identified as curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC), respectively, by comparison of mass spectroscopy, 1 H-NMR, and 13 C-NMR data with those in the literature (Song et al., 2001) .
Endothelial cell culture
Human endothelial cells (ECV304) were cultured in 75-cm 2 culture flasks and maintained in Ham's F12K medium (Sigma). Cell medium was supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin solution, 30 g/ml of endothelial cell growth supplement and 100 g/ml of heparin (Sigma).
MTT assay for cell viability
Endothelial cells were plated at a density of 4 × 10 4 cells/300 l in 48-well plates and the cell viability was determined by the conventional MTT reduction assay. MTT is tetrazolium salt cleaved to formazan by the mitochondrial respiratory chain enzyme suc- cinate dehydrogenase. After incubation, cells were treated with the MTT solution (final concentration, 1 mg/ml) for 2 h. The dark blue formazan crystals formed in intact cells were solubilized with dimethyl sulfoxide and the absorbance at 570 nm was measured with a microplate reader.
Western blotting analysis for HO-1 expression
After treatment, endothelial cells (3 × 10 6 cells/3 ml in 60 mm dish) were collected and washed with phosphate-buffered saline (PBS). After centrifugation, cell lysis was carried out at 4 o C by vigorous shaking for 15 min in RIPA buffer [150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl (pH 7.4), 50 mM glycerophosphate, 20 mM NaF, 20 mM EGTA, 1 mM DTT, 1 mM Na3VO4 and protease inhibitors]. After centrifugation at 14,800 × g for 15 min, the supernatant was separated and stored at -70 o C until use. The protein concentration was determined by using the BCA protein assay kit (Pierce, Rockford, IL). After addition of sample loading buffer, protein samples were electrophoresed on a 12.5% SDS-polyacrylamide gel. Proteins were transferred to polyvinylidene difluoride blots at 300 mA for 6 h. The blots were blocked for 1 h at room temperature in fresh blocking buffer (0.1% Tween 20 in Tris-buffered saline, pH 7.4, containing 5% non-fat dried milk). Dilutions (1:1000) of primary antibodies were made in PBS with 3% non-fat dried milk. Following three washes with PBST (PBS and 0.1% Tween 20), the blots were incubated with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) in PBS with 3% non-fat dried milk for 1 h at room temperature. The blots were washed again three times in PBST buffer, and transferred proteins were incubated with ECL substrate solution (Amersham Pharmacia Biotech, Piscataway, NJ) for 1 min according to the manufacturer's instructions followed by visualization with X-ray film.
HO activity assay
Endothelial cells (2.5 × 10 6 cells) were treated with vehicle, CoPP (positive control) or curcuminoids for 6 h. Cell pellets were re-suspended in magnesium supplemented potassium phosphate solution [MgCl-PBS; 100 mM potassium phosphate and 2 mM magnesium chloride; pH 7.4] and subjected to three freeze-thaw cycles for release of cytoplasmic HO-1 proteins. HO-1 enzymatic assay used a reaction mixture containing 100 mM PBS, 2 mM MgCl 2 , 3 mg of rat liver cytosol, 0.8 mM NADPH, 2 mM glucose-6-phosphate (Sigma), 0.2 U of glucose-6-phosphate dehydrogenase and 20 M enzyme substrate hemin (Porphyrin Products) plus 400 l of sample. The reaction was made up to a final volume of 1 ml for each sample and was incubated at 37 o C for 1 h in the dark. Chloroform was added to terminate the reaction, and bilirubin was extracted following centrifugation, and measured by spectrophotometry reading the difference in absorbance between 464 and 530 nm ( = 40 mM -1 cm -1 ). The protein concentration in each sample was determined with a Bradford protein assay, and the HO-1 activities were expressed in picomoles of bilirubin formed per milligram of protein per hour.
Statistical analysis
Data are expressed as mean ± S.E.M.. Statistical analysis in this study includes ANOVA and the Post-Hoc group comparisons after Bonferroni and Scheffé-procedures. The P values ＜ 0.05 were considered as significant.
Results
Effects of curcuminoids on HO-1 expression and HO activity
Based on the fact that HO-1 is highly inducible in endothelial cells treated with curcumin (Motterlini et al., 2000) , we wondered whether other curcumin derivatives, DMC and BDMC, would also affect the expression of HO-1 in human endothelial cells. We found that pure curcumin, DMC, and BDMC all significantly increased HO-1 expression after 6 h of incubation (Figure 2) . However, despite displaying a similar basic chemical structure, three compounds affected the pattern of HO-1 protein inducibility in a different fashion. For example, removal of one methoxy group from the molecule of curcumin, as in DMC, affected HO-1 expression slightly. Removal of both methoxy groups, as in BDMC, significantly decreased HO-1 expression. Consistent with these results, HO activity also differed for each curcuminoid tested in this study ( Figure 3) ; the order being curcumin ＞ DMC ＞ BDMC. It has to be noted that HO activity and HO-1 expression were analyzed in non-cytotoxic concentrations of curcuminoids.
Effects of curcuminoids on endothelial cell injury caused by H 2 O 2
It has been reported that curcumin protects endothelial cells against oxidative injury (Motterlini et al., 2000; Scapagnini et al., 2002; Foresti et al., 2005) . We therefore examined whether DMC and BDMC could also be cytoprotective against oxidative injury in endothelial cells. Treatment of endothelial cells with H2O2 resulted in marked decrease in cell viability (Figure 4) . However, pre-incubation of the cells for 6 h with curcumin, DMC or BDMC significantly attenuated H2O2-mediated damage and restored cell viability, notably, in a different fashion. The activity at 10 M was found to be highest with curcumin, followed by DMC and BDMC.
Role of endothelial HO-1 in curcuminoid-induced cytoprotection
Previous studies have shown that endothelial HO-1 provides cytoprotection against oxidative injury (Motterlini et al., 2000; Scapagnini et al., 2002; Foresti et al., 2005 ). Thus, we tested whether curcuminoid-induced HO-1 expression could facilitate cytoprotective effect. Endothelial cells were initially pretreated with 10 M of each curcuminoid for 6 h in Protective effects of curcuminoids against oxidative stress. Endothelial cells were initially pre-incubated for 6 h in the presence of indicated concentrations of curcuminoids. Then the medium was removed, and cells were exposed to 1 mM H2O2 for 2 h. Cell viability was measured spectrophotometrically using MTT assay. Data are expressed as the mean ± S.E.M. of five independent experiments. *, P ＜ 0.05 versus control and # , P ＜ 0.05 versus H2O2. the absence or presence of SnPP, an inhibitor of HO activity. The cells were then exposed to hydrogen peroxide for 2 h followed by an assessment of cell viability. As shown in Figure 5 , SnPP significantly reversed the protective effect afforded by curcuminoids. In addition, protection comparable to the potent cytoprotective curcumin was observed when the cells were pre-incubated with the HO-1 inducer CoPP or bilirubin, one of enzymatic products of HO-1 ( Figure 5 ). Other products, carbon monoxide and Fe 2+ , did not provide a notable cytoprotection (data not shown).
Signaling pathway(s) of curcuminoid-induced endothelial HO-1 expression
The activation of intracellular signaling pathway was important for HO-1 induction. Generally, HO-1 expression is induced by stimuli that activate the mitogen-activated protein kinases (MAPKs) (Iles et al., 2005; . Three major subgroups of the MAPK family have been identified to include extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun NH 2 -terminal kinase (JNK) and p38 MAPK. Depending on the stimuli specificity, contradictory results on the regulatory role of different MAPK pathways for HO-1 expression were observed (Iles et al., 2005) . In the case of curcumin, the activation of p38 MAPK pathway was found to be involved in HO-1 expression (Balogun et al., 2003) . To investigate the signal transduction pathway(s) involved in regulating HO-1 expression in response to curcuminoids, we examined the effects of three pharmacological inhibitors of signaling intermediates on HO-1 protein levels. As shown in Figure 6 , we found that treatment of endothelial cells with p38 MAPK inhibitor (SB203580) reduced curcuminoidinduced HO-1 expression. Neither JNK inhibitor (SP600125) nor MAP/ERK kinase inhibitor (U0126) had a significant effect.
Discussion
The potent antioxidant curcumin has been considered as therapeutic agents for various pathologic conditions, including cancer, viral infection, inflammation, hypertension, and atherosclerosis (Duvoix et al., 2005) . Based on the fact that the cytoprotective HO-1 is highly inducible in endothelial cells treated with curcumin (Motterlini et al., 2000) , we aimed to investigate whether other curcumin derivatives present in turmeric would also affect the expression of endothelial HO-1 and to test whether HO-1 expression by these compounds would facilitate their cytoprotective effects.
Michael reaction acceptors (olefins or acetylenes conjugated to electron-withdrawing groups) constitute a major class of phase-II enzyme inducers, and their inducer potency was closely correlated with their reactivities with nucleophiles in the Michael reaction (Prestera et al., 1995) . Not surprisingly, curcumin and its two derivatives, which contain two Michael reaction acceptors ( , -unsaturated carbonyl group) in their own molecules, induced the phase-II enzyme HO-1 in endothelial cells (Dinkova-Kostova and Talalay, 1999) . However, our results clearly show that the pattern of HO-1 protein inducibility differed for each curcuminoid tested in this study (Figure 2 ), indicating that even subtle Figure 5 . Effects of curcuminoid-induced HO-1 and bilirubin on H2O2-mediated cellular injury. Endothelial cells were exposed for 6 h to 10 M curcuminoids, 20 M CoPP or indicated concentrations of bilirubin in the presence or absence of 50 M SnPP. After this pretreatment, cells were challenged for 2 h with 1mM H2O2. After this treatment, cells were washed and viability was assessed using MTT assay. Each bar represents the mean ± S.E.M. of 6 independent experiments. *, P ＜ 0.05 versus control; # , P ＜ 0.05 versus H2O2; $ , P ＜ 0.05 versus same treatment plus SnPP.
changes of the chemical structure can significantly affect the potency of curcuminoids to enhance endothelial HO-1 expression and HO activity. In fact, the main difference among the three curcuminoids is the number of methoxy groups present (none for BDMC, one for DMC, and two for curcumin; see chemical structure in Figure 1 ). The presence of methoxy groups in the ortho position on the aromatic ring is already known to noticeably enhance the bioactivities of curcuminoids (Motohashi et al., 2000; Skrzypczak-Jankun et al., 2003) . Indeed, all three forms of curcuminoids could induce endothelial HO-1 expression; however, we found that curcumin with two ortho methoxy groups was the most active form among the curcuminoids present in turmeric (Figure 2) . The rank order of HO activity at 10 M is curcumin, DMC and BDMC (Figure 3) . Interestingly, cytoprotective capacities of curcuminoids against oxidative injury caused by H2O2 exposure were in the order: curcumin ＞ DMC ＞ BDMC (Figure 4) , which is the same as the order of HO activity. Based on these findings, it is suggested that the presence of methoxy groups in the ortho position on the aromatic ring of curcuminoids is essential to enhance endothelial HO-1 expression and cytoprotection in human endothelial cells.
Of interest is our finding that, in our experimental setting, the observed cytoprotective properties of curcuminoids were considerably linked to their ability to affect the levels of HO-1 expression and HO activity. Pre-incubation of human endothelial cells with curcuminoids resulted in enhanced resistance to oxidative injury; this effect was partly attributable to HO-1 expression, as the inhibitor of HO activity (SnPP) significantly reduced cytoprotective activities of curcuminoids ( Figure 5) . Moreover, the HO-1 inducer CoPP mimicked the cytoprotective effect of curcumin ( Figure 5 ), which is further supporting recent reports showing that HO-1 expression confers a cytoprotection upon endothelial cells (Motterlini et al., 2000) .
The heme degradation enzyme, HO-1, has been proposed to have roles in cytoprotection and in the regulation of endothelial inflammation (Balla et al., 2005) . The molecular basis of the cytoprotective/ anti-inflammatory action of endothelial HO-1 remains to be fully elucidated, but the products of heme degradation such as carbon monoxide and bilirubin seem to be responsible for the cytoprotective/antiinflammatory effect attributed to HO-1. In our study, we showed that bilirubin, produced by reduction of biliverdin, was responsible for cytoprotective action of HO-1 (Figure 5 ), further supporting our conclusion that endothelial cytoprotection afforded by curcuminoids is mediated via HO-1 expression. Although we have shown that HO-1 expression by curcuminoids is cytoprotective in human endothelial cells, we do not exclude the possibility that these compounds will stimulate the expression of other defense enzymes, as is already known as inducers of other cytoprotective enzymes (Commandeur and Vermeulen, 1996) , and that cytoprotective activity will be achieved via the concerted action of the multiple pathways that may be activated by curcuminoids.
The flavonoid-induced signaling mechanisms involved in HO-1 expression are poorly understood. Several studies have focused on the activation of the MAPKs that contribute to the induction of HO-1 (Iles et al., 2005; , and report that the flavonoid curcumin induces HO-1 expression via the activation of p38 MAPK pathway (Balogun et al., 2003). For these reasons, we used specific pharmacological inhibitors to test signaling pathways in order to elucidate the important components in curcuminoid-mediated endothelial HO-1 expression. Our results showed that DMC and BDMC, as previously reported for curcumin (Balogun et al., 2003) , induced p38 MAPK-dependent HO-1 expression ( Figure 6 ).
In conclusion, we report, for the first time, that the presence of methoxy groups in the ortho position on the aromatic ring of curcuminoids is essential to enhance endothelial HO-1 expression and that HO-1 expression by curcuminoids is cytoprotective against oxidative injury. Our results may be useful to design more efficacious HO-1 inducers which could be considered as promising pharmacological agents in the development of therapeutic approaches for the prevention or treatment of endothelial diseases caused by oxidative damages.
